Lipidomics studies on macrophages - RAW 264.7 cells treated with Kdo2-Lipid A and compactin

Introduction | Browse | Search | Download
Mouse-over the above links for more information

Treatment details

LM ID Analyte Treatment Time(hrs) Sample ID Value Units
LMFA03080004 11,12-EET cPLA2i 1.0 BCD110605C28 0.087 pmol/ml medium
LMFA03080004 11,12-EET cPLA2i 1.0 BCD110605C30 0.083 pmol/ml medium
LMFA03080004 11,12-EET cPLA2i 1.0 BCD110605C29 0.115 pmol/ml medium
LMFA03080004 11,12-EET cPLA2i 20.0 BCD110605C64 0.226 pmol/ml medium
LMFA03080004 11,12-EET cPLA2i 20.0 BCD110605C66 0.249 pmol/ml medium
LMFA03080004 11,12-EET cPLA2i 20.0 BCD110605C65 0.27 pmol/ml medium
LMFA03080004 11,12-EET PLDi 1.0 BCD110605C16 0.111 pmol/ml medium
LMFA03080004 11,12-EET PLDi 1.0 BCD110605C17 0.102 pmol/ml medium
LMFA03080004 11,12-EET PLDi 1.0 BCD110605C18 0.097 pmol/ml medium
LMFA03080004 11,12-EET PLDi 20.0 BCD110605C54 0.252 pmol/ml medium
LMFA03080004 11,12-EET PLDi 20.0 BCD110605C52 0.308 pmol/ml medium
LMFA03080004 11,12-EET PLDi 20.0 BCD110605C53 0.292 pmol/ml medium
LMFA03080004 11,12-EET KDO+cPLA2i 1.0 BCD110605C32 0.079 pmol/ml medium
LMFA03080004 11,12-EET KDO+cPLA2i 1.0 BCD110605C31 0.091 pmol/ml medium
LMFA03080004 11,12-EET KDO+cPLA2i 1.0 BCD110605C33 0.08 pmol/ml medium
LMFA03080004 11,12-EET KDO+cPLA2i 20.0 BCD110605C68 0.164 pmol/ml medium
LMFA03080004 11,12-EET KDO+cPLA2i 20.0 BCD110605C69 0.188 pmol/ml medium
LMFA03080004 11,12-EET KDO+cPLA2i 20.0 BCD110605C67 0.177 pmol/ml medium
LMFA03080004 11,12-EET KDO+PLDi 1.0 BCD110605C19 0.099 pmol/ml medium
LMFA03080004 11,12-EET KDO+PLDi 1.0 BCD110605C20 0.084 pmol/ml medium
LMFA03080004 11,12-EET KDO+PLDi 1.0 BCD110605C21 0.089 pmol/ml medium
LMFA03080004 11,12-EET KDO+PLDi 20.0 BCD110605C56 0.188 pmol/ml medium
LMFA03080004 11,12-EET KDO+PLDi 20.0 BCD110605C57 0.231 pmol/ml medium
LMFA03080004 11,12-EET KDO+PLDi 20.0 BCD110605C55 0.214 pmol/ml medium
LMFA03080004 11,12-EET KDO+ATP+cPLA2i 1.0 BCD110605C37 0.105 pmol/ml medium
LMFA03080004 11,12-EET KDO+ATP+cPLA2i 1.0 BCD110605C38 0.077 pmol/ml medium
LMFA03080004 11,12-EET KDO+ATP+cPLA2i 1.0 BCD110605C39 0.083 pmol/ml medium
LMFA03080004 11,12-EET KDO+ATP+cPLA2i 20.0 BCD110605C74 0.111 pmol/ml medium
LMFA03080004 11,12-EET KDO+ATP+cPLA2i 20.0 BCD110605C75 0.101 pmol/ml medium
LMFA03080004 11,12-EET KDO+ATP+cPLA2i 20.0 BCD110605C73 0.114 pmol/ml medium
LMFA03080004 11,12-EET KDO+ATP+PLDi 1.0 BCD110605C25 0.102 pmol/ml medium
LMFA03080004 11,12-EET KDO+ATP+PLDi 1.0 BCD110605C27 0.101 pmol/ml medium
LMFA03080004 11,12-EET KDO+ATP+PLDi 1.0 BCD110605C26 0.106 pmol/ml medium
LMFA03080004 11,12-EET KDO+ATP+PLDi 20.0 BCD110605C61 0.129 pmol/ml medium
LMFA03080004 11,12-EET KDO+ATP+PLDi 20.0 BCD110605C62 0.119 pmol/ml medium
LMFA03080004 11,12-EET KDO+ATP+PLDi 20.0 BCD110605C63 0.128 pmol/ml medium
LMFA03080004 11,12-EET KDO + ATP 1.0 BCD110605C15 0.093 pmol/ml medium
LMFA03080004 11,12-EET KDO + ATP 1.0 BCD110605C14 0.1 pmol/ml medium
LMFA03080004 11,12-EET KDO + ATP 1.0 BCD110605C13 0.099 pmol/ml medium
LMFA03080004 11,12-EET KDO + ATP 20.0 BCD110605C49 0.133 pmol/ml medium
LMFA03080004 11,12-EET KDO + ATP 20.0 BCD110605C50 0.145 pmol/ml medium
LMFA03080004 11,12-EET KDO + ATP 20.0 BCD110605C51 0.119 pmol/ml medium
LMFA03080004 11,12-EET KDO 1.0 BCD110605C08 0.087 pmol/ml medium
LMFA03080004 11,12-EET KDO 1.0 BCD110605C07 0.097 pmol/ml medium
LMFA03080004 11,12-EET KDO 1.0 BCD110605C09 0.113 pmol/ml medium
LMFA03080004 11,12-EET KDO 20.0 BCD110605C45 0.31 pmol/ml medium
LMFA03080004 11,12-EET KDO 20.0 BCD110605C44 0.245 pmol/ml medium
LMFA03080004 11,12-EET KDO 20.0 BCD110605C43 0.257 pmol/ml medium
LMFA03080004 11,12-EET C 0.0 BCD110605C03 0.083 pmol/ml medium
LMFA03080004 11,12-EET C 0.0 BCD110605C01 0.108 pmol/ml medium